News

It’s no secret. Clinical trials are getting more complicated and this is driving up the cost of developing new drugs. As recently reported by the Tufts Center for the Study of Drug Development

Although there are many obstacles that need to be overcome to take an investigational therapeutic successfully through to regulatory approval, the vast majority of issues really come down to two

Although pharmacogenetics is a relatively new field of study, it has already made a significant contribution to the standard treatment options for several common cancers. However, it is the positive

Starting a phase 1 trial can be exciting and nerve-racking, especially for First Time in Human studies. In most cases, Phase 1 trials are the first opportunity to assess if the properties of a

The world of clinical development is changing. The rapid pace of scientific & technological advances, the rise of personalised medicine and patient engagement, escalating R&D costs, and increased

Southern Star Research is thrilled to announce that our Managing Director, Dr. David Lloyd was awarded Sector Advocate 2017 by ARCS Australia. The acknowledgement comes after David’s tireless work